Table 2.
Overall and breast cancer specific survival and 95% confidence interval for female invasive breast cancer cases diagnosed in San Francisco by neighborhood and race-ethnicity, San Francisco, 2006–2015
| 5-year | ||
|---|---|---|
| Area | Overall | BCa-specific |
| 1. Center-South | 83.2 (78.8–86.8) | 89.7 (85.9–92.5) |
| 2. Center-West | 86.0 (82.1–89.1) | 91.5 (88.2–93.9) |
| 3. Center-East | 85.4 (79.9–89.5) | 89.8 (84.8–93.2) |
| 4. East | 88.3 (82.9–92.1) | 94.1 (89.9–96.6) |
| 5. Southeast | 82.7 (78.6–86.1) | 89.7 (86.1–92.4) |
| 6. Southwest | 85.2 (82.0–88.0) | 91.9 (89.3–93.9) |
| 7. West | 85.6 (82.5–88.1) | 92.1 (89.7–94.0) |
| 8. North | 88.3 (84.9–91.0) | 94.0 (91.3–95.8) |
| 9. Northeast | 80.5 (77.1–83.5) | 88.5 (85.6–90.9) |
| Race/ethnicity | ||
| NHW | 84.9 (83.1–86.5) | 92.0 (90.6–93.2) |
| B/AA | 71.1 (65.4–76.1) | 81.8 (76.5–86.0) |
| H/L | 84.2 (79.6–87.8) | 90.0 (86.1–92.8) |
| AANHPI | 87.7 (85.8–89.3) | 92.3 (90.8–93.6) |
| Stage | ||
| Stage I-IIa | 91.3 (90.2–92.3) | 97.3 (96.6–97.9) |
| Stage IIb and higher | 69.0 (66.0–71.9) | 75.2 (72.3–77.9) |
| Stage unknown | 56.5 (46.5–65.4) | 73.9 (63.5–81.7) |
| Molecular subtype | ||
| HR+/HER2+ | 87.3 (83.6–90.2) | 93.0 (89.8–95.2) |
| HR+/HER2- | 87.9 (86.5–89.2) | 94.2 (93.1–95.0) |
| HR-/HER2+ | 82.3 (76.3–86.9) | 86.5 (80.8–90.6) |
| TNBC | 71.6 (66.8–75.8) | 77.8 (73.2–81.7) |
| Unclassified | 73.0 (67.8–77.4) | 83.9 (79.3–87.6) |